Loading...
Loading...
Among the 4 tracked institutional investors we monitor, LIMN (LIMINATUS PHARMA INC.) is held with a combined value of $166.80K across 783,196 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $116.47K. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$166.80K
Total Shares Held
783,196
Institutional Holders
4
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $116.47K | 0.00% | +855.2% |
| 2 | VANGUARD GROUP INC | $44.79K | 0.00% | - |
| 3 | STATE STREET CORP | $3.27K | 0.00% | - |
| 4 | BlackRock, Inc. | $2.28K | 0.00% | -0.0% |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of LIMN with a position worth $116.47K, representing 0.00% of their portfolio. In total, 4 institutional investors hold LIMN with a combined value of $166.80K.
Institutional investors hold $166.80K worth of LIMN stock across 4 positions. The largest institutional holder is CITADEL ADVISORS LLC with $116.47K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For LIMN, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their LIMN positions.
Last Close
$0.10
2026-07-28
YTD
-83.7%
0% of 52-week range